Eesti  - Tooteinfo

Estonia  - Product information

SPC - Toote omaduste kokkuvõte
PIL - Pakendi infoleht

SPC - Summary of product characteristics
PIL - Package leaflet

  

  

Share link to Organon SPC-OnLine content


Select authentication method to unlock restricted content.

by e-Mail (preffered)

by intranet (soon to be disabled)


Country of origin:

Please insert you business e-mail:

Eg.: name.surname
@
Eg.: organon.com

Unlock key has ben sent to your business e-mail
Access level = .

Unlock key rejected to E-mail submited. Please contact administrator.

xxxxxxxxx

You will be redirected to INTRANET starting point.

Arcoxia

Arcoxia

etoricoxib

etoricoxib

60 mg

60 mg

õhukese polümeerikattega tabletid

film coated tablets

90 mg

90 mg

õhukese polümeerikattega tabletid

film coated tablets

120 mg

120 mg

õhukese polümeerikattega tabletid

film coated tablets

* Sisaldab infot erinevate tugevuste ja ravimvormide kohta.

* Combined content for different dosage & pharmaceutical forms.

Cerazette

Cerazette

Desogestrel

Desogestrel

75 mcg

75 mcg

õhukese polümeerikattega tabletid

film coated tablets

Co-Renitec

Co-Renitec

Enalapril, Hydrochlorothiazide

Enalapril, Hydrochlorothiazide

20 mg/12.5 mg

20 mg/12.5 mg

tabletid

tablets

Diprosalic

Diprosalic

betamethasone, salicylic acid

betamethasone, salicylic acid

0.5 mg/g/20 mg/g

0.5 mg/g/20 mg/g

nahalahus

lotion

Elocon

Elocom

mometasone furoate

mometasone furoate

1 mg/g

1 mg/g

kreem

cream

1 mg/g

1 mg/g

nahalahus

lotion

1 mg/g

1 mg/g

salv

ointment

* Sisaldab infot erinevate tugevuste ja ravimvormide kohta.

* Combined content for different dosage & pharmaceutical forms.

Fosavance

Fosavance

Fosavance-*

Fosavance-*

70 mg/5,600 IU

70 mg/5,600 IU

tabletid

tablets

Nasonex

Nasonex

Nasonex-*

Nasonex-*

50 mcg

50 mcg

suspensioon

nasal suspension

Nexplanon

Implanon NXT

etonogestrel

etonogestrel

68 mg

68 mg

implantaat

implant for subdermal use

NuvaRing

NuvaRing

NuvaRing-*

NuvaRing-*

0.120 mg/0.015 mg 24h

0.120 mg/0.015 mg per 24 hours

vaginaalravivahend

vaginal delivery system

Ontruzant

Ontruzant

Ontruzant-*

Ontruzant-*

150 mg

150 mg

infusioonilahuse kontsentraadi pulber

powder for concentrate for solution for infusion

Sinemet

Sinemet

Sinemet-*

Sinemet-*

25 mg/250 mg

25 mg/250 mg

tabletid

tablets

25 mg/100 mg

25 mg/100 mg

tabletid

tablets

* Sisaldab infot erinevate tugevuste ja ravimvormide kohta.

* Combined content for different dosage & pharmaceutical forms.

  

 APP version: _v2-759 | level: 0 

See platvorm sisaldab Eestis turustatavate ravimite ja vaktsiinide ravimi omaduste kokkuvõtteid (SPC) ja pakendi infolehti (PIL).
Teiste registreeritud ravimite ja vaktsiinide SPCd ja PILid on kättesaadavad Eesti Ravimiameti kodulehel olevas ravimiregistris.
Lisainfoks palun võtke ühendust dpoc.estonia@organon.com. Privaatsuspoliitika

This platform contains Summary of Product Characteristics (SPC) and Package Leaflets (PIL) for medicinal products and vaccines that are marketed in Estonia.
SPCs and PILs for other registered medicinal products and vaccines are available on the website of Estonian State Agency of Medicines.
For more information please contact dpoc.estonia@organon.com. Privacy Policy